Highlander Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.02M | Buy |
|
|||||
|
2023
Q4 | $656K | Sell |
|
|||||
|
2023
Q3 | $646K | Buy |
|
|||||
|
2023
Q2 | $409K | Sell |
|
|||||
|
2023
Q1 | $484K | Hold |
|
|||||
|
2022
Q4 | $498K | Sell |
|
|||||
|
2022
Q3 | $458K | Buy |
|
|||||
|
2022
Q2 | $406K | Sell |
|
|||||
|
2022
Q1 | $512K | Sell |
|
|||||
|
2021
Q4 | $444K | Sell |
|
|||||
|
2021
Q3 | $542K | Sell |
|
|||||
|
2021
Q2 | $560K | Hold |
|
|||||
|
2021
Q1 | $653K | Buy |
|
|||||
|
2020
Q4 | $220K | Sell |
|
|||||
|
2020
Q3 | $217K | Sell |
|
|||||
|
2020
Q2 | $315K | Hold |
|
|||||
|
2020
Q1 | $229K | Sell |
|
|||||
|
2019
Q4 | $263K | Sell |
|
|||||
|
2019
Q3 | $241K | Sell |
|
|||||
|
2019
Q2 | $364K | Buy |
|
|||||
|
2019
Q1 | $571K | Sell |
|
|||||
|
2018
Q4 | $618K | Sell |
|
|||||
|
2018
Q3 | $894K | Sell |
|
|||||
|
2018
Q2 | $1.58M | Buy |
|
|||||
|
2018
Q1 | $1.08M | Sell |
|
|||||
|
2017
Q4 | $1.29M | Sell |
|
|||||
|
2017
Q3 | $1.4M | Buy |
|
|||||
|
2017
Q2 | $2.54M | Buy |
|
|||||
|
2017
Q1 | $2.21M | Buy |
|
|||||
|
2016
Q4 | $1.84M | Buy |
|
|||||
|
2016
Q3 | $881K | Buy |
|
|||||
|
2016
Q2 | $513K | Buy |
|
|||||
|
2016
Q1 | $458K | Buy |
|
|||||
|
2015
Q4 | $10K | Hold |
|
|||||
|
2015
Q3 | $8K | Hold |
|
|||||
|
2015
Q2 | $9K | Hold |
|
|||||
|
2015
Q1 | $10K | Sell |
|
|||||
|
2014
Q4 | $15K | Hold |
|
|||||
|
2014
Q3 | $13.7K | Hold |
|
|||||
|
2014
Q2 | $13.3K | Hold |
|
|||||
|
2014
Q1 | $13.5K | Hold |
|
|||||
|
2013
Q4 | $10.2K | Hold |
|
|||||
|
2013
Q3 | $9.62K | Sell |
|
|||||
|
2013
Q2 | $13.9K | Buy |
|